Cover Image
市場調查報告書

MediPoint:主動脈覆膜支架 - 現在/未來的主要企業

MediPoint: Aortic Stent Grafts - Current and Future Players

出版商 GlobalData 商品編碼 318822
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:主動脈覆膜支架 - 現在/未來的主要企業 MediPoint: Aortic Stent Grafts - Current and Future Players
出版日期: 2014年10月31日 內容資訊: 英文 105 Pages
簡介

主動脈覆膜支架,是為了加強動脈瘤這種動脈的薄弱部位,最常使用的裝置。血管支架,置入患者的動脈,設計成能在動脈瘤的上下好好地封住。不僅僅是腹部主動脈血管瘤,也用於胸部主動脈瘤的治療。

本報告提供全球主動脈覆膜支架市場相關調查分析、新加入企業、正在開發的開發中產品、現在/未來的競爭情形相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 競爭評估

  • 概要
  • 主要上市產品

第4章 開發平台評估

  • 概要
  • 產品簡介

第5章 現在/未來的主要企業

  • 概要
  • 企業策略趨勢
  • 企業簡介
    • Cook Medical
    • Endologix
    • Gore Medical
    • Medtronic
    • Terumo Corporation
    • Altura Medical
    • Aptus Endosystems
    • Bolton Medical
    • Braile Biomedica
    • B. Braun
    • Cardiatis
    • LeMaitre Vascular
    • Lifetech Scientific
    • Getinge Group
    • Grikin Advanced Materials
    • Johnson & Johnson's Cordis Corporation
    • Jotec
    • Lombard Medical
    • MicroPort Scientific Corporation
    • Nano Endoluminal
    • TriVascular
    • Weike Medical Apparatus and Instrument
    • YTH Biological Material Scitech

第6章 附錄

圖表

目錄
Product Code: GDME1030FPR

Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. Since their introduction in patients in 1991, aortic stent graft devices have gained wide acceptance and availability, with their adoption fueled in great part by advances in stent-graft design and by a variety of devices for various anatomic features. Over time, these devices have gained traction for use in patients with ruptured aneurysms because they are minimally invasive and have shorter recovery times.

The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading doctors, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Aortic Stent Grafts.
  • Competitor assessment including device approval analysis.
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice.

Reasons to buy

  • Gain a high level view of the trends shaping and driving the Aortic Stent Grafts market.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Competitive Assessment

  • 3.1. Overview
  • 3.2. Key Marketed Products
    • 3.2.1. Endovascular Aneurysm Repair and Thoracic Endovascular Aneurysm Repair Products

4. Pipeline Assessment

  • 4.1. Overview
  • 4.2. Product Profiles
    • 4.2.1. Altura Medical Endograft
    • 4.2.2. Cordis INCRAFT
    • 4.2.3. EndoSpan Horizon
    • 4.2.4. EndoSpan Nexus
    • 4.2.5. MicroPort Scientific Castor Branched Stent Graft System
    • 4.2.6. BiFlow Medical Novel Side-Branch Stent
    • 4.2.7. Endoluminal Sciences Endograft Mechanism
    • 4.2.8. Medtronic Valiant Mona LSA Stent Graft System
    • 4.2.9. Endologix Ventana Fenestrated Stent Graft

5. Current and Future Players

  • 5.1. Overview
  • 5.2. Trends in Corporate Strategy
  • 5.3. Company Profiles
    • 5.3.1. Cook Medical
    • 5.3.2. Endologix
    • 5.3.3. Gore Medical
    • 5.3.4. Medtronic
    • 5.3.5. Terumo Corporation
    • 5.3.6. Altura Medical
    • 5.3.7. Aptus Endosystems
    • 5.3.8. Bolton Medical
    • 5.3.9. Braile Biomedica
    • 5.3.10. B. Braun
    • 5.3.11. Cardiatis
    • 5.3.12. LeMaitre Vascular
    • 5.3.13. Lifetech Scientific
    • 5.3.14. Getinge Group
    • 5.3.15. Grikin Advanced Materials
    • 5.3.16. Johnson & Johnson's Cordis Corporation
    • 5.3.17. Jotec
    • 5.3.18. Lombard Medical
    • 5.3.19. MicroPort Scientific Corporation
    • 5.3.20. Nano Endoluminal
    • 5.3.21. TriVascular
    • 5.3.22. Weike Medical Apparatus and Instrument
    • 5.3.23. YTH Biological Material Scitech

6. Appendix

  • 6.1. Bibliography
  • 6.2. Abbreviations
  • 6.3. Research Methodology
    • 6.3.1. Overview
    • 6.3.2. Coverage
    • 6.3.3. Secondary Research
  • 6.4. Physicians and Specialists Included in this Study
    • 6.4.1. Christopher Abularrage, MD, FACS
    • 6.4.2. Gaspar Mestres Alomar, MD
    • 6.4.3. Enio Buffolo, MD, PhD
    • 6.4.4. Ludovic Canaud, MD, PhD
    • 6.4.5. Holger Eggebrecht, MD
    • 6.4.6. Daisuke Fukui, MD, PhD
    • 6.4.7. Germano Melissano, MD
    • 6.4.8. Dr. Raghuram Sekhar MS, FRCS (Edinburgh), FRCS (Glasgow)
    • 6.4.9. Ferdinand Serracino-Inglott, MD, MSc, FRCSI, FRCS (Gen Surg), DIC
    • 6.4.10. Jiang Xiong, MD, PhD
  • 6.5. Primary Research
    • 6.5.1. Primary Research - Key Opinion Leader Interviews
    • 6.5.2. Primary Research - Physician and Industry Interviews
    • 6.5.3. Expert Panel Validation
  • 6.6. Forecasting Methodology
  • 6.7. About the Authors
    • 6.7.1. Analysts
    • 6.7.2. Global Head of Healthcare
  • 6.8. About MediPoint
  • 6.9. About GlobalData
  • 6.10. Disclaimer

List of Tables

  • Table 1: Zenith Family Marketed Products
  • Table 2: Zenith AAA SWOT
  • Table 3: Zenith TAA SWOT
  • Table 4: Endologix's Marketed Products
  • Table 5: AFX Endovascular SWOT
  • Table 6: IntuiTrak Powerlink System SWOT
  • Table 7: Gore Medical's Marketed Products
  • Table 8: Gore AAA Product SWOT
  • Table 9: Gore TAA Product SWOT
  • Table 10: Medtronic's Marketed Products
  • Table 11: Medtronic AAA Product SWOT
  • Table 12: Medtronic TAA Product SWOT
  • Table 13: Terumo Corporation Marketed Products
  • Table 14: Terumo Corporation AAA Product SWOT
  • Table 15: SWOT Analysis - Altura Medical Endograft
  • Table 16: SWOT Analysis - Cordis INCRAFT
  • Table 17: SWOT Analysis - EndoSpan Horizon
  • Table 18: SWOT Analysis - EndoSpan Nexus
  • Table 19: SWOT Analysis - MicroPort Scientific Castor Branched Stent Graft System
  • Table 20: SWOT Analysis - BiFlow Medical Novel Side-Branch Stent
  • Table 21: SWOT Analysis - Endoluminal Sciences Endograft Mechanism
  • Table 22: SWOT Analysis - Medtronic Valiant Mona LSA Stent Graft
  • Table 23: SWOT Analysis - Endologix Ventana Fenestrated Stent Graft
  • Table 24: Company Profile - Cook Medical
  • Table 25: Cook Medical Marketed Products
  • Table 26: SWOT Analysis - Cook Medical
  • Table 27: Company Profile - Endologix Inc.
  • Table 28: Endologix Marketed Products
  • Table 29: Endologix Pipeline Products
  • Table 30: SWOT Analysis - Endologix Inc.
  • Table 31: Company Profile - Gore Medical
  • Table 32: Gore Medical Marketed Products
  • Table 33: SWOT Analysis - Gore Medical
  • Table 34: Company Profile - Medtronic
  • Table 35: Medtronic Marketed Products
  • Table 36: SWOT Analysis - Medtronic
  • Table 37: Company Profile - Terumo Corporation
  • Table 38:Terumo Corporation Marketed Products
  • Table 39: SWOT Analysis - Terumo Corporation
  • Table 40: Company Profile - Altura Medical Inc.
  • Table 41: Altura Medical Inc. Marketed Products
  • Table 42: SWOT Analysis - Altura Medical Inc.
  • Table 43: Company Profile - Aptus Endosystems, Inc.
  • Table 44: Aptus Endosystems Inc. Marketed Products
  • Table 45: SWOT Analysis - Aptus Endosystems Inc.
  • Table 46: Company Profile - Bolton Medical
  • Table 47: Bolton Medical Marketed Products
  • Table 48: SWOT Analysis - Bolton Medical
  • Table 49: Company Profile - Braile Biomedica
  • Table 50: Braile Biomedica Marketed Products
  • Table 51: SWOT Analysis - Braile Biomedica
  • Table 52: Company Profile - B. Braun
  • Table 53: B. Braun Marketed Products
  • Table 54: SWOT Analysis - B. Braun
  • Table 55: Company Profile - Cardiatis
  • Table 56: Cardiatis Marketed Products
  • Table 57: SWOT Analysis - Cardiatis
  • Table 58: Company Profile - LeMaitre Vascular
  • Table 59: LeMaitre Vascular Medical Marketed Products
  • Table 60: SWOT Analysis - LeMaitre Vascular
  • Table 61: Company Profile - Lifetech Scientific
  • Table 62: Lifetech Scientific Marketed Products
  • Table 63: SWOT Analysis - Lifetech Scientific
  • Table 64: Company Profile - Getinge Group
  • Table 65: Getinge Group Marketed Products
  • Table 66: SWOT Analysis - Getinge Group
  • Table 67: Company Profile - Grikin Advanced Materials
  • Table 68: Grikin Advanced Materials Marketed Products
  • Table 69: SWOT Analysis - Grikin Advanced Materials
  • Table 70: Company Profile - Johnson & Johnson Cordis Corporation
  • Table 71: Cordis Corporation's Pipeline Product
  • Table 72: SWOT Analysis - Cordis Corporation
  • Table 73: Company Profile - Jotec
  • Table 74: Jotec's Marketed Products
  • Table 75: SWOT Analysis - Jotec
  • Table 76: Company Profile - Lombard Medical
  • Table 77: Lombard Medical Marketed Products
  • Table 78: SWOT Analysis - Lombard Medical
  • Table 79: Company Profile - Microport Scientific Corporation
  • Table 80: MicroPort Scientific Marketed Products
  • Table 81: SWOT Analysis - MicroPort Scientific
  • Table 82: Company Profile - Nano Endoluminal
  • Table 83: Nano Endoluminal Medical Marketed Products
  • Table 84: SWOT Analysis - Nano Endoluminal
  • Table 85: Company Profile - TriVascular
  • Table 86: TriVascular Marketed Products
  • Table 87: SWOT Analysis - TriVascular

List of Figures

  • Figure 1: Aortic Stent Graft Primary Research, Supply and Demand-Side Interviews
Back to Top